Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

DCLK1 variants are associated across schizophrenia and attention deficit/hyperactivity disorder

Håvik, Bjarte, Degenhardt, Franziska A., Johansson, Stefan, Fernandes, Carla P. D., Hinney, Anke, Scherag, André, Lybæk, Helle, Djurovic, Srdjan, Christoforou, Andrea, Ersland, Kari M., Giddaluru, Sudheer, O'Donovan, Michael Conlon, Owen, Michael John, Craddock, Nicholas John, Mühleisen, Thomas W., Mattheisen, Manuel, Schimmelmann, Benno G., Renner, Tobias, Warnke, Andreas, Herpertz-Dahlmann, Beate, Sinzig, Judith, Albayrak, Özgür, Rietschel, Marcella, Nöthen, Markus M., Bramham, Clive R., Werge, Thomas, Hebebrand, Johannes, Haavik, Jan, Andreassen, Ole A., Cichon, Sven, Steen, Vidar M. and Le Hellard, Stéphanie 2012. DCLK1 variants are associated across schizophrenia and attention deficit/hyperactivity disorder. PLoS ONE 7 (4) , e35424. 10.1371/journal.pone.0035424

[img]
Preview
PDF - Published Version
Available under License Creative Commons Attribution.

Download (553kB) | Preview

Abstract

Doublecortin and calmodulin like kinase 1 (DCLK1) is implicated in synaptic plasticity and neurodevelopment. Genetic variants in DCLK1 are associated with cognitive traits, specifically verbal memory and general cognition. We investigated the role of DCLK1 variants in three psychiatric disorders that have neuro-cognitive dysfunctions: schizophrenia (SCZ), bipolar affective disorder (BP) and attention deficit/hyperactivity disorder (ADHD). We mined six genome wide association studies (GWASs) that were available publically or through collaboration; three for BP, two for SCZ and one for ADHD. We also genotyped the DCLK1 region in additional samples of cases with SCZ, BP or ADHD and controls that had not been whole-genome typed. In total, 9895 subjects were analysed, including 5308 normal controls and 4,587 patients (1,125 with SCZ, 2,496 with BP and 966 with ADHD). Several DCLK1 variants were associated with disease phenotypes in the different samples. The main effect was observed for rs7989807 in intron 3, which was strongly associated with SCZ alone and even more so when cases with SCZ and ADHD were combined (P-value = 4×10−5 and 4×10−6, respectively). Associations were also observed with additional markers in intron 3 (combination of SCZ, ADHD and BP), intron 19 (SCZ+BP) and the 3′UTR (SCZ+BP). Our results suggest that genetic variants in DCLK1 are associated with SCZ and, to a lesser extent, with ADHD and BP. Interestingly the association is strongest when SCZ and ADHD are considered together, suggesting common genetic susceptibility. Given that DCLK1 variants were previously found to be associated with cognitive traits, these results are consistent with the role of DCLK1 in neurodevelopment and synaptic plasticity.

Item Type: Article
Date Type: Publication
Status: Published
Schools: MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Medicine
Neuroscience and Mental Health Research Institute (NMHRI)
Subjects: Q Science > QH Natural history > QH426 Genetics
R Medicine > R Medicine (General)
R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Publisher: PLoS
ISSN: 1932-6203
Date of First Compliant Deposit: 30 March 2016
Last Modified: 04 Jun 2017 04:42
URI: http://orca.cf.ac.uk/id/eprint/43229

Citation Data

Cited 8 times in Google Scholar. View in Google Scholar

Cited 12 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics